[Ahn, J. K., Moon, H. J. (2009). Changes in aqueous vascular endothelial growth factor and pigment epithelium-derived factor after ranibizumab alone or combined with verteporfin for exudative age-related macular degeneration. Amer. J. Ophthalmol., 148, 718–724.10.1016/j.ajo.2009.06.01219674731]Search in Google Scholar
[Anonymous (2001). Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework. Clin. Pharmacol. Ther., 69, 89–95.]Search in Google Scholar
[Askou, A. L., Alsing, S., Benckendorff, J. N. E., Holmgaard, A., Mikkelsen, J. G., Aagaard, L., Bek, T., Corydon, T. J. (2019). Suppression of choroidal neovascularization by AAV-based dual-acting antiangiogenic gene therapy. Mol. Ther. Nucl. Acids, 16, 38–50.10.1016/j.omtn.2019.01.012639370730825671]Search in Google Scholar
[Bai, Y., Liang, S., Yu, W., Zhao, M., Huang, L., Zhao, M., Li, X. (2014). Semaphorin 3A blocks the formation of pathologic choroidal neovascularization induced by transforming growth factor beta. Mol. Vision, 20, 1258–1270.]Search in Google Scholar
[Bakri, N. M., Ramachandran, V., Kee, H. F., Subrayan, V., Isa, H., Ngah, N. F., Mohamad, N. A., Mooi, C. S., Mun, C. Y., Ismail, P., Ismail, F., Sukiman, E. S., Sulaiman, W. A. W. (2018). Copy number variation in VEGF gene as a biomarker of susceptibility to age-related macular degeneration. Egypt. J. Med. Hum. Gen.,19, 207–213.10.1016/j.ejmhg.2017.09.003]Search in Google Scholar
[Balne, P. K., Agrawal, R., Bijin, V., Lee, B., Ghosh, A., Sethy, S., Agrawal, M., Narayanan, R., Connolly, J. (2018). Dataset of plasma and aqueous humor cytokine profiles in patients with exudative age related macular degeneration and polypoidal choroidal vasculopathy. Data in Brief, 19, 1570–1573.10.1016/j.dib.2018.05.085614176530246075]Search in Google Scholar
[Berg, K., Pedersen, T. R., Sandvik, L., Bragadottir, R. (2015). Comparison of ranibizumab and bevacizumab for neovascular age-related macular degeneration according to LUCAS tret-and-extend protocol. Ophthalmology, 122, 146–152.10.1016/j.ophtha.2014.07.04125227499]Search in Google Scholar
[Betsholtz, C. (2004). Insight into the physiological functions of PDGF through genetic studies in mice. Cytokine Growth Factor Rev.,15, 215–228.10.1016/j.cytogfr.2004.03.00515207813]Search in Google Scholar
[Bhutto, I. A., McLeod, D. S., Hasegawa, T., Kim, S. Y., Merges, C., Tong, P., Lutty, G. A. (2006). Pigment epithelium-derived factor (PEDF) and vascular endothelial growth factor (VEGF) in aged human choroid and eyes with age-related macular degeneration. Exp. Eye Res., 82 (1), 99–110.10.1016/j.exer.2005.05.007493284716019000]Search in Google Scholar
[Cabral, T., Lima, L. H., Mello, L. G. M., Polido, J., Correa, E. P., Oshima, A., Duong, J., Serracarbassa, P., Regatieri, C. V., Mahajan, V. B., Belfort, R. J. (2018). Bevacizumab injection in patients with neovascular age-related macular degeneration increases angiogenic biomarkers. Ophthalm. Retina, 2 (1), 31–37.10.1016/j.oret.2017.04.004578331429376143]Search in Google Scholar
[Castellino, N., Longo, A., Avitabile, T., Russo, A., Fallico, M., Bonfiglio, V., Toro, M. D., Rejdak, R., Nowomiejska, K., Murabito, P., Furino, C., Reibaldi, M. (2018). Circulating insulin-like growth factor-1: A new clue in the pathogenesis of age-related macular degeneration. Aging, 10 (12), 4241–4247.10.18632/aging.101727632664830594908]Search in Google Scholar
[Chakravarthy, U., Bailey, C., Brown, D., Campochiaro, P., Chittum, M., Csaky, K., Tufail, A., Yates, P., Cech, P., Giraudon, M., Delmar, P., Szczesny, P., Sahni, J., Boulay, A., Nagel, S., Fürst-Recktenwald, S., Schwab, D. (2017). Phase I trial of anti-vascular endothelial growth factor/anti-angiopoietin 2 bispecific antibody RG7716 for neovascular age-related macular degeneration. Ophthalmol. Retina, 1, 474–485.10.1016/j.oret.2017.03.00331047438]Search in Google Scholar
[Chen, L. J., Ma, L., Chu, W. K., Lai, T. Y. Y., Chen, H., Brelen, M. E., Rong, S. S., Young, A. L., Tam, P. O. S., Zhang, M., Pang, C. P. (2016). Identification of PGF as a new gene for neovascular age-related macular degeneration in a Chinese population. Invest. Ophthalmol. Vis. Sci.,57, 1714–1720.10.1167/iovs.IOVS-15-1867727064391]Search in Google Scholar
[Chiu, C. J., Conley, Y. P., Gorin, M. B., Gensler, G., Lai, C. Q., Shang, F., Taylor, A. (2011). Associations between genetic polymorphisms of insulin-like growth factor axis genes and risk for age-related macular degeneration. Invest. Ophthalmol. Vis. Sci., 52, 9099–9107.10.1167/iovs.11-7782323196722058336]Search in Google Scholar
[Clemons, T. E., Milton, R. C., Klein, R., Seddon, J. M., Ferris, 3rd F. L. (2005). Risk factors for the incidence of advanced age-related macular degeneration in the age-related eye disease study (AREDS). AREDS report No. 19. Ophthalmology,112, 533–539.]Search in Google Scholar
[Clijn, J. M., Buitendijk, G. H. S., Prokofyeva, E., Alves, D., Cachulo, M. L., Khawaja, A. P., Cougnard-Gregoire, A., Merle, B. M. J., Korb, C., Erke, M. G. et al. (2017). Prevalence of age-related macular degeneration in Europe. Ophthalmology, 124 (12), 1753–1763.10.1016/j.ophtha.2017.05.035575546628712657]Search in Google Scholar
[Evans, J. R., Fletcher, A. E., Wormald, R. P. (2004). Age-related macular degeneration causing visual impairment in people 75 years or older in Britain: An add-on study to the medical research council trial of assessment and management of older people in the community. Ophthalmology, 111, 513–517.10.1016/j.ophtha.2003.07.01215019328]Search in Google Scholar
[Fallah, A., Sadeghinia, A., Kahroba, H., Samadi, A., Heidari, H. R., Bradaran, B., Zeinali, S., Molavi, O. (2019). Therapeutic targeting of angiogenesis molecular pathways in angiogenesis-dependent diseases. Biomed. Pharmacother.,110, 775–785.10.1016/j.biopha.2018.12.02230554116]Search in Google Scholar
[Farnoodian, M., Wang, S., Dietz, J., Nickells, R. W., Sorenson, C. M., Sheibani, N. (2017). Negative regulators of angiogenesis: Important targets for treatment of exudative AMD. Clin. Sci. (Lond), 131 (15), 1763–1780.10.1042/CS20170066601684728679845]Search in Google Scholar
[Garcia-Garcia, L., Recalde, S., Hernandez, M., Bezunartea, J., Rodriguez-Madoz, J. R., Johnen, S., Diarra, S., Marie, C., Izsvak, Z., Ivics, Z. et al. (2017). Long-term PEDF release in rat iris and retinal epithelial cells after sleeping beauty transposon-mediated gene delivery. Mol. Ther. Nucl. Acids, 9, 1–11.10.1016/j.omtn.2017.08.001558339529246287]Search in Google Scholar
[Grassmann, F., Friedrich, U., Fauser, S., Schick, T., Milenkovic, A., Schulz, H. L., von Strachqitz, C. N., Bettecken, T., Lichtner, P., Meitinger, T., Arend, N., Wolf, A., Haritoglou, C., Rudolph, G., Chakravarthy, U. (2015). A candidate gene association study identifies DAPL1 as a female-specific susceptibility locus for age-related macular degeneration (AMD). NeuroMol. Med.,17 (2), 111–120.10.1007/s12017-015-8342-1441916225680934]Search in Google Scholar
[Gu, X., Yu, X., Dai, H. (2014). Intravitreal injection of ranibizumab for treatment of age-related macular degeneration: Effects on serum VEGF concentration. Curr. Eye Res.,39 (5), 518–521.10.3109/02713683.2013.84889924215127]Search in Google Scholar
[Gupta, D., Gupta, V., Singh, V., Chawla, S., Parveen, F., Agrawal, S., Phadke, S. R. (2014). Study of polymorphisms in CX3CR1, PLEKHA1 and VEGF genes as risk factors for age-related macular degeneration in Indian patients. Arch. Med. Res.,45, 489–494.10.1016/j.arcmed.2014.07.00525050486]Search in Google Scholar
[Huber, M., Wachtlin, J. (2012). Vitreous levels of proteins implicated in angiogenesis are modulated in patients with retinal or choroidal neovascularization. Ophthalmologica, 228, 188–193.10.1159/00033995222868384]Search in Google Scholar
[Huo, X., Li, Y., Jiang, Y., Sun, X., Gu, L., Guo, W., Sun, D. (2015). Inhibition of ocular neovascularization by co-inhibition of VEGF-A and PLGF. Cell Physiol. Biochem., 35, 1787–1796.10.1159/00037399025832861]Search in Google Scholar
[Jaffe, G. J., Ciulla, T. A., Ciardella, A. P., Devin, F., Dugel, P. U., Eandi, C. M., Masonson, H., Mones, J., Pearlman, J. A., Quaranta-El Maftouhi, M., Ricci, F., Westby, K., Patel, S. C. (2017). Dual antagonism of PDGF and VEGF in neovascular age-related macular degeneration. Ophthalmology,124, 224–234.10.1016/j.ophtha.2016.10.01028029445]Search in Google Scholar
[Kazlauskas, A. (2017). PDGFs and their receptors. Gene, 614, 1–7.10.1016/j.gene.2017.03.003672814128267575]Search in Google Scholar
[Kersten, E., Paun, C. C., Schellevis, R. L., Hoyng, C. B., Delcourt, C., Lengyel, I., Peto, T., Ueffing, M., Klaver, C. C. W., Dammeier, S., den Hollander, A. I., de Jong, E. K. (2018). Systemic and ocular fluid compunds as potential biomarkers in age-related macular degeneration. Surv. Ophthalmol., 63, 9–39.10.1016/j.survophthal.2017.05.00328522341]Search in Google Scholar
[Kim, J., Park, J. R., Choi, J., Park, I., Hwang, Y., Bae, H., Kim, Y., Choi, W., Yang, J. M., Han, S. et al. (2019). Tie2 activation promotes choriocapillary regeneration for alleviating neovascular age-related macular degeneration. Sci. Adv.,5, eaau6732.]Search in Google Scholar
[Kinnunen, K., Petrovski, G., Moe, M. C., Berta, A., Kaarniranta, K. (2012). Molecular mechanisms of retinal pigment epithelium damage and development of age-related macular degeneration. Acta Ophthalmol.,90, 299–309.10.1111/j.1755-3768.2011.02179.x22112056]Search in Google Scholar
[Lambert, N. C., El Shelmani, H., Singh, M. K., Mansergh, F. C., Wride, M. A., Padilla, M., Keegan, D., Hogg, R. E., Ambati, B. K. (2016). Risk factors and biomarkers of age-related macular degeneration. Progr. Retinal Eye Res.,54, 64–102.10.1016/j.preteyeres.2016.04.003499263027156982]Search in Google Scholar
[Lambert, N. G., Zhang, X., Rai, R. R., Uehara, H., Choi, S., Carroll, L. S., Das, S. K., Cahoon, J. M., Kirk, B. H., Bentley, B. M., Ambati, B. K. (2016). Subretinal AAV2.COMP-Ang1 suppresses choroidal neovascularization and vascular endothelial growth factor in a murine model of age-related macular degeneration. Exper. Eye Rese., 145, 248–257.10.1016/j.exer.2016.01.009586203826775053]Search in Google Scholar
[Li, R., Du, J. H., Yao, G. M., Yao, Y., Zhang, J. (2019). Autophagy: A new mechanism for regulating VEGF and PEDF expression in retinal pigment epithelium cells. Int. J. Ophthalmol., 12 (4), 557–562.]Search in Google Scholar
[Masli, S., Sheibani, N., Cursiefen, C., Zieske, J. (2014). Matricellular protein thrombospondin: Influence on ocular angiogenesis, wound healing and immuneregulation. Curr. Eye Res.,39 (8), 759–774.10.3109/02713683.2013.877936427864724559320]Search in Google Scholar
[Mesquita, J., Castro-de-Sousa, J. P., Vaz-Pereira, S., Neves, A., Passarinha, L. A., Tomaz, C. T. (2018). Vascular endothelial growth factors and placenta growth factor in retinal vasculopathies: Current research and future perspectives. Cytokine Growth Factor Rev., 39, 102–115.10.1016/j.cytogfr.2017.11.00529248329]Search in Google Scholar
[Mitchell, P., Liew, G., Gopinath, B., Wong, T. Y. (2018). Age-related macular degeneration. Lancet, 392, 1147–1159.10.1016/S0140-6736(18)31550-2]Search in Google Scholar
[Ng, D. S., Yip, Y. W., Bakthavatsalam, M., Chen, L. J., Ng, T. K., Lai, T. Y., Pang, C. P., Brelen, M. E. (2017). Elevated angiopoietin 2 in aqueous of patients with neovascular age related macular degeneration correlates with disease severity at presentation. Sci. Rep., 27 (7), 45081.]Search in Google Scholar
[Ng, E. W. M., Adamis, A. P. (2005). Targeting angiogenesis, the underlying disorder in neovascular age-related macular degeneration. Can. J. Ophthalmol., 40, 352–368.10.1016/S0008-4182(05)80078-X]Search in Google Scholar
[Owen, C. G., Jarrar, Z., Wormald, R., Cook, D. G., Fletcher, A. E., Rudnicka, A. R. (2012). The estimated prevalence and incidence of late stage age related macular degeneration in the UK. Brit. J. Ophthalmol., 96, 752–756.10.1136/bjophthalmol-2011-301109332963322329913]Search in Google Scholar
[Rakic, J. M., Lambert, V., Devy, L., Luttun, A., Carmeliet, P., Claes, C., Nguyen, L., Foidart, J. M., Noël, A., Munaut, C. (2003). Placental growth factor, a member of the VEGF family, contributes to the development of choroidal neovascularization. Invest. Ophthalmol. Vis. Sci., 44, 3186–3193.10.1167/iovs.02-109212824270]Search in Google Scholar
[Rastogi, N., Smith, T. (2016). Association of age-related macular degeneration and reticular macular disease with cardiovascular disease. Surv. Ophthalmol., 61 (4), 422–433.10.1016/j.survophthal.2015.10.00326518628]Search in Google Scholar
[Rein, D. B., Wittenborn, J. S., Zhang, X., Honeycutt, A. A., Lesesne, S. B., Saaddine, J. (2009). Vision health cost-effectiveness study group. Forecasting age-related macular degeneration through the year 2050. Arch. Ophthalmol., 127 (4), 533–540.]Search in Google Scholar
[Rosenthal, R., Wohlleben, H., Malek, G., Schlichting, L., Thieme, H., Bowes Rickman, C., Strauss, O. (2004). Insulin-like growth factor-1 contributes to neovascularization in age-related macular degeneration. Biochem. Biophys. Res. Commun., 323, 1203–1208.10.1016/j.bbrc.2004.08.21915451424]Search in Google Scholar
[Sall, J. W., Klisovic, D. D., O’Dorisio, M. S., Katz, S. E. (2004). Somatostatin inhibits IGF-1 mediated induction of VEGF in human retinal pigment epithelial cells. Exper. Eye Res.,79 (4), 465–476.10.1016/j.exer.2004.06.00715381031]Search in Google Scholar
[Storkebaum, E., Carmeliet, P. (2004). VEGF: A critical player in neurodegeneration. J. Clin. Invest., 113 (1), 14–18.10.1172/JCI2068230088814702101]Search in Google Scholar
[Tamhane, M., Cabrera-Ghayouri, S., Abelian, G., Viswanath, V. (2019). Review of biomarkers in ocular matrices: Challenges and opportunities. Pharm. Res., 36, 40.10.1007/s11095-019-2569-8634439830673862]Search in Google Scholar
[Tong, J. P., Chan, W. M., Liu, D. T. L., Lai, T. Y. Y., Choy, K. W., Pang, C. P., Lam, D. S. C. (2006). Aqueous humor levels of vascular endothelial growth factor and pigment epithelium-derived factor in polypoidal choroidal vasculopathy and choroidal neovascularization. Amer. J. Ophthalmol., 141, 456–462.10.1016/j.ajo.2005.10.01216490490]Search in Google Scholar
[Tosi, G. M., Orlandini, M., Galvagni, F. (2018). The controversial role of TGF-ß in neovascular age-related macular degeneration pathogenesis. Int. J. Mol. Sci.,19, 3363.]Search in Google Scholar
[Tsai, D. C., Charng, M. J., Lee, F. L., Hsu, W. M., Chen, S. J. (2006). Different plasma levels of vascular endothelial growth factor and nitric oxide between patients with choroidal and retinal neovascularization. Ophthalmologica, 220 (4), 246–251.10.1159/000093079]Search in Google Scholar
[Van Bergen, T., Etienne, I., Cunningham, F., Moons, L., Schlingemann, R. O., Feyen, J. H. M., Stitt, A. W. (2019). The role of placental growth factor (PIGF) and its receptor system in retinal vascular diseases. Progr. Retinal Eye Res., 69, 116–136.10.1016/j.preteyeres.2018.10.006]Search in Google Scholar
[van Lookeren Campagne, M., LeCouter, J., Yaspan, B. L., Ye, W. (2014). Mechanisms of age-related macular degeneration and therapeutic opportunities. J. Pathol., 232, 151–164.10.1002/path.4266]Search in Google Scholar
[Wong, W. L., Su, X., Li, X., Cheung, C. M., Klein, R., Cheng, C. Y., Wong, T. Y. (2014). Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: A systematic review and meta-analysis. Lancet Glob. Heal, 2, e106–e115.10.1016/S2214-109X(13)70145-1]Search in Google Scholar
[Zarranz-Ventura, J., Fernandez-Robredo, P., Recalde, S., Salinas-Alaman, A., Borras-Cuesta, F., Dotor, J., Garcia-Layana, A. (2013). Transforming growth factor-beta inhibition reduces progression of early choroidal neovascularization lesions in rats: P17 and P144 peptides. PLoS ONE, 8 (5), e65434.10.1371/journal.pone.0065434366924923741494]Search in Google Scholar
[Zehetner, C., Kirchmair, R., Neururer, S. B., Kralinger, M. T., Bechrakis, N. E., Kieselbach, G. F. (2014). Systemic upregulation of PDGF-B in patients with neovascular AMD. Invest. Ophthalmol. Vis. Sci., 55, 337–344.10.1167/iovs.13-1297824334449]Search in Google Scholar